Therapeutic efficacy of dl-α-lipoic acid on cyclosporine A induced renal alterations

European Journal of Pharmacology

Volumn 571, Issue 2-3, 2007, Pages 209-214

  Amudha, Ganapathy ^a   Josephine, Anthony ^a   Mythili, Yenjerla ^a   Sundarapandiyan, Rajaguru ^a   Varalakshmi, Palaninathan ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

ATPase; Cyclosporine A; Lipoic acid; Lysosomal enzyme; Serum constituent

Indexed keywords

ACID PHOSPHATASE; ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOSINE TRIPHOSPHATASE (MAGNESIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BETA GALACTOSIDASE; BETA GLUCOSIDASE; CATHEPSIN D; CREATININE; CYCLOSPORIN A; GAMMA GLUTAMYLTRANSFERASE; LACTATE DEHYDROGENASE; N ACETYL BETA GLUCOSAMINIDASE; THIOCTIC ACID; UREA; URIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG EFFICACY; ENZYME ACTIVITY; KIDNEY FUNCTION; KIDNEY INJURY; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BIOLOGICAL MARKERS; CYCLOSPORINE; DISEASE MODELS, ANIMAL; ENZYMES; KIDNEY; KIDNEY DISEASES; MALE; PROTECTIVE AGENTS; RATS; RATS, WISTAR; THIOCTIC ACID; TIME FACTORS;

EID: 34548483664     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.05.047     Document Type: Article

References (57)

1. + ATPase activity and reduces lipofuscin accumulation in discrete brain regions of aged rats. Ann. N. Y. Acad. Sci 1019 (2004) 350-354
2. Barany P., Stenvinkel P., and Ottosson-Seeberger A. Effects of 6 weeks of vitamin E administration on renal haemodynamic alterations following a single dose of neural in healthy. Nephrol. Dial. Transplant 16 (2001) 580-584
3. +-ATPase in cyclosporine A-treated rats: immunocytochemical analysis of alpha1 subunit by confocal laser scanning microscopy imaging. Dig. Dis. Sci. 44 (1999) 1643-1649
4. Biber J., Steiger B., Haase W., and Murer H. A higher yield preparation for kidney brush border membranes: different behaviour of lysosomal markers. Biochim. Biophys. Acta 647 (1981) 169-176
5. Biewenga G.P., Haenen G.R., and Bast A. The pharmacology of the antioxidant lipoic acid. Gen. Pharmacol. 29 (1997) 315-331
6. Bilska A., and Wlodek L. Lipoic acid-the drug of the future. Pharmacol. Rep. 57 (2005) 570-577
7. Bonting S.L. Sodium-potassium activated adenosine triphosphatase and cation transport. In: Bittar E.E. (Ed). Membrane and Ion Transport. Interscience vol. I (1970), London 257-363
8. Burdmann E.A., Andoh T.F., Yu L., and Bennet W.M. Cyclosporine nephrotoxicity. Semin. Nephrol. 23 (2003) 465-476
9. Busauschina A., Schnuelle P., and van der Woude F.J. Cyclosporine nephrotoxicity. Transplant. Proc. 36 (2004) 229S-233S
10. Caraway W.T. Uric acid. In: Seligson D. (Ed). Standard Methods of Clinical Chemistry (1963), Academic press, New York 239-247
11. Chanussot F., and Benkoel L. Prevention by dietary (n-6) polyunsaturated phosphatidylcholines of intrahepatic cholestasis induced by cyclosporine A in animals. Life Sci. 73 (2003) 381-392
12. Clarke H., and Ryan M.P. Cyclosporine A-induced alterations in magnesium homeostasis in the rat. Life Sci. 64 (1999) 1295-1306
13. Durkan A.M., Hodson E.M., Willis N.S., and Craig J.C. Immunosuppressive agents in childhood nephrotic syndrome: a meta-analysis of randomized controlled trials. Kidney Int. 59 (2001) 1919-1927
14. Farthing M.J., and Clark M.L. Nature of the toxicity of cyclosporin A in the rat. Biochem. Pharmacol. 30 (1981) 3311-3316
15. Fricker G., and Fahr A. Mechanisms of hepatic transport of cyclosporin A: an explanation for its cholestatic action?. Yale J Biol Med. 70 (1997) 379-390
16. 2+-ATPase from erythrocyte membranes. Biochim. Biophys. Acta 728 (1983) 281-288
17. +-ATPase activities in high glucose-treated human erythrocytes. Free Radic. Biol. Med. 29 (2000) 1122-1128
18. Josephine A., Veena C.K., Amudha G., Preetha S.P., and Varalakshmi P. Evaluating the effect of sulphated polysaccharides on cyclosporine A induced oxidative renal injury. Mol. Cell. Biochem. 287 (2006) 101-108
19. Kagan V.E., Shvedova A., Serbinova E., Khan S., Swanson C., Powell R., and Packer L. Dihydrolipoic acid-a universal antioxidant both in the membrane and in the aqueous phase. Reduction of peroxyl, ascorbyl and chromanoxyl radicals. Biochem. Pharmacol. 44 (1992) 1637-1649
20. Kawai Y., and Anno K. Mucopolysaccharide-degrading enzymes from the liver of the squid, Ommastrephes sloani pacificus. I. Hyaluronidase. Biochim. Biophys. Acta 242 (1971) 428-436
21. King J. The dehydrogenases or oxidoreductases-lactate dehydrogenase. In: Van D. (Ed). Practical Clinical Enzymology (1965), Nostrand Company Limited, London 83-93
22. King J. The transferases-alanine and aspartate transaminases. In: Van D. (Ed). Clinical Enzymology (1965), Nostrand Company Limited, London 121-138
23. King J. The hydrolases-acid and alkaline phosphatase. In: Van D. (Ed). Practical Clinical Enzymology (1965), Nostrand Company Limited, London 191-208
24. Kuzniar J., Marchewka Z., Krasnowski R., Boratynska M., Dlugosz A., and Klinger M. Enzymuria and low molecular weight protein excretion as the differentiating marker of complications in the early post kidney transplantation period. Int. Urol. Nephrol. 38 (2006) 753-758
25. Liptak P., and Ivanyi B. Primer: histopathology of calcineurin-inhibitor toxicity in renal allografts. Nat. Clin. Pract. Nephrol. 2 (2006) 398-404
26. Lowry O.H., Rosenbrough N.J., Farr A.I., and Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
27. Machlin L.J., and Bendich A. Free radical tissue damage: protective role of antioxidant nutrients. FASEB J. 1 (1987) 441-445
28. Malarkodi K.P., Balachandar A.V., and Varalakshmi P. The influence of lipoic acid on adriamycin induced nephrotoxicity in rats. Mol. Cell. Biochem. 247 (2003) 15-22
29. Mardini M., Mihailidou A.S., Wong A., and Rasmussen H.H. Cyclosporine and FK506 differentially regulate the sarcolemmal Na(+)-K(+) pump. J. Pharmacol. Exp. Ther. 297 (2001) 804-810
30. Maruhn D. Rapid colorimetric assay of beta-galactosidase and N-acetyl-beta-glucosaminidase in human urine. Clin. Chim. Acta 73 (1976) 453-461
31. e Collogue' International Do Pont-A-Mousson (1983), Masson, Paris 943-945
32. Mohamadin A.M., El-Beshbishy H.A., and El-Mahdy M.A. Green tea extract attenuates cyclosporine A-induced oxidative stress in rats. Pharmacol. Res. 51 (2005) 51-57
33. Mythili Y., Sudharsan P.T., Selvakumar E., and Varalakshmi P. Protective effect of DL-alpha-lipoic acid on cyclophosphamide induced oxidative cardiac injury. Chem. Biol. Interact. 151 (2004) 13-19
34. Natelson S., Scott M.L., and Beffa C. A rapid method for the estimation of urea in biologic fluids. Am. J. Clin. Pathol. 21 (1951) 275-281
35. 2+-ATPase activities in normal, regenerating and malignant cells. Biochim. Biophys. Acta 684 (1982) 67-74
36. Orlowski M., and Meister A. Isolation of gamma glutamyl transpeptidase from hog kidney. J. Biol. Chem. 240 (1965) 338-347
37. Owen J.A., Iggo B., Scandrett F.J., and Stewart C.P. The determination of creatinine in plasma or serum, and in urine; a critical examination. Biochem. J. 58 (1954) 426-437
38. Packer L., Kraemer K., and Rimbach G. Molecular aspects of lipoic acid in the prevention of diabetes complications. Nutrition 17 (2001) 888-895
39. Paul L.C., and de Fijter J.H. Cyclosporine-induced renal dysfunction. Transplant. Proc. 36 (2004) 224S-228S
40. Persson H.L., Svensson A.I., and Brunk U.T. Alpha-lipoic acid and alpha-lipoamide prevent oxidant-induced lysosomal rupture and apoptosis. Redox. Rep. 6 (2001) 327-334
41. Persson H.L., Yu Z., Tirosh O., Eaton J.W., and Brunk U.T. Prevention of oxidant-induced cell death by lysosomotropic iron chelators. Free. Radic. Biol. Med. 34 (2003) 1295-1305
42. Pons M., Plante I., LeBrun M., Gourde P., Simard M., Grenier L., Thibault L., Labrecque G., and Beauchamp D. Protein-rich diet attenuates cyclosporin A-induced renal tubular damage in rats. J. Ren. Nutr. 13 (2003) 84-92
43. Ponticelli C. Cyclosporine: from renal transplantation to autoimmune diseases. Ann. N Y Acad. Sci. 1051 (2005) 551-558
44. Rezzani R., Rodella L., and Bianchi R. Early metabolic changes in peripheral blood cells of renal transplant recipients treated with cyclosporine A. Int. J. Immunopharmacol. 21 7 (1999) 455-462
45. Rosenblit P.D., Metzger R.P., and Wick A.N. Effect of streptozotocin diabetes on acid phosphatase and selected glycosidase activities of serum and various rat organs. Proc. Soc. Exp. Biol. Med. 145 (1974) 244-248
46. 2+-ATPase activities and biogenic amine concentrations in phenylketonuria. Clin. Biochem. 35 (2002) 281-285
47. Smith A.R., Shenvi S.V., Widlansky M., Suh J.H., and Hagen T.M. Lipoic acid as a potential therapy for chronic diseases associated with oxidative stress. Curr. Med. Chem. 11 (2004) 1135-1146
48. Streck E.L., Zugno A.I., Tagliari B., Franzon R., Wannmacher C.M., Wajner M., and Wyse A.T. Inhibition of rat brain Na+, K+-ATPase activity induced by homocysteine is probably mediated by oxidative stress. Neurochem. Res. 26 (2001) 1195-1200
49. Takaoka M., Ohkita M., Kobayashi Y., Yuba M., and Matsumura Y. Protective effect of alpha-lipoic acid against ischaemic acute renal failure in rats. Clin. Exp. Pharmacol. Physiol. 29 (2002) 189-194
50. Teichert J., Tuemmers T., Achenbach H., Preiss C., Hermann R., Ruus P., and Preiss R. Pharmacokinetics of alpha-lipoic acid in subjects with severe kidney damage and end-stage renal disease. J. Clin. Pharmacol. 45 (2005) 313-328
51. Thirunavukkarasu V., Anitha Nandhini A.T., and Anuradha C.V. Lipoic acid attenuates hypertension and improves insulin sensitivity, kallikrein activity and nitrite levels in high fructose-fed rats. J. Comp. Physiol. 174 (2004) 587-592
52. Tsuboi K., Tazuma S., Ochi H., and Chayama K. Hydrophilic bile salts have a cytoprotective effect against cyclosporine A-induced cholestasis through enhanced canalicular membrane fluidity and transporter activity. Hepatol. Res. 25 (2003) 38-47
53. +-ATPase activity by cyclosporin A. Kidney Int. 43 (1993) 246-251
54. Weir M.R., Klasen D.K., and Shen S.Y. Acute effects of cyclosporine on renal function in healthy humans. Transplant. Proc. 21 (1989) 915-917
55. Wollin S.D., and Jones P.J. Alpha-lipoic acid and cardiovascular disease. J. Nutr. 133 (2003) 3327-3330
56. Wongmekiat O., and Thamprasert K. Investigating the protective effects of aged garlic extract on cyclosporin induced nephrotoxicity in rats. Clin. Pharmacol. 19 (2005) 555-562
57. +-ATPase activity induced by cyclosporin A. J. Korean Med. Sci. 17 (2002) 625-632